microdosing glp 1 alzheimer's How GLP-1 drugs became a wellness 'craze' Could diabetes and weight loss

2017;7(8) doi: 10.1136/bmjopen-2017-016242

No annual contracts

doi: 10.3389/fmed.2022.875430 Summary Keywords glucagon-like peptide-1 receptor agonist (GLP-1RA), incretin based therapy, glucose-depent insulinotropic peptide (GIP), dual agonists, tirzepatide, type 2 diabetes Citation Gallwitz B (2022) Clinical perspectives on the use of the GIP/GLP-1 receptor agonist tirzepatide for the treatment of type-2 diabetes and obesity

They even have meals tailored to people taking GLP-1 medications, featuring nutrient-dense, higher-protein options vetted by nutritionists

For starters, many clinical studies have proven they are effective treatments for weight loss, and theres also the fact that the legitimate GLP-1 market is over $47 billion

Pharmacol Ther